Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Janssen

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Virchows Archiv : an International Journal of Pathology|September 3, 2014
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor sizeSandra Steffens, Frederik C Roos, Martin Janssen, et al.
Human Pathology|October 13, 2014
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinomaSandra Steffens, Martin Janssen, Frederik C Roos, et al.
European Urology Focus|July 28, 2018
Robot-assisted Kidney Transplantation with Regional Hypothermia Using Grafts with Multiple Vessels After Extracorporeal Vascular Reconstruction: Results from the European Association of Urology Robotic Urology Section Working GroupGiampaolo Siena, Riccardo Campi, Karel Decaestecker, et al.
BMC Cancer|June 3, 2014
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinomaFrederik C Roos, Sandra Steffens, Kerstin Junker, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2019
Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinomaSebastian Hölters, Oybek Khalmurzaev, Alexey Pryalukhin, et al.
Prostate Cancer and Prostatic Diseases|April 17, 2022
LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trialCarsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2023
Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trialCarsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, et al.
Journal of Medical Virology|February 14, 2025
Tumor Necrosis Factor-Alpha Inhibits the Replication of Patient-Derived Archetype BK Polyomavirus While Activating Rearranged StrainsLise Lauterbach-Rivière, Lucia Thuringer, Pascal Feld, et al.
World Journal of Urology|June 21, 2020
Robotic-assisted kidney transplantation in obese recipients compared to non-obese recipients: the European experienceThomas Prudhomme, Jean Baptiste Beauval, Marine Lesourd, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Virchows Archiv : an International Journal of Pathology|September 3, 2014
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor sizeSandra Steffens, Frederik C Roos, Martin Janssen, et al.
Human Pathology|October 13, 2014
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinomaSandra Steffens, Martin Janssen, Frederik C Roos, et al.
European Urology Focus|July 28, 2018
Robot-assisted Kidney Transplantation with Regional Hypothermia Using Grafts with Multiple Vessels After Extracorporeal Vascular Reconstruction: Results from the European Association of Urology Robotic Urology Section Working GroupGiampaolo Siena, Riccardo Campi, Karel Decaestecker, et al.
BMC Cancer|June 3, 2014
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinomaFrederik C Roos, Sandra Steffens, Kerstin Junker, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2019
Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinomaSebastian Hölters, Oybek Khalmurzaev, Alexey Pryalukhin, et al.
Prostate Cancer and Prostatic Diseases|April 17, 2022
LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trialCarsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2023
Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trialCarsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, et al.
Journal of Medical Virology|February 14, 2025
Tumor Necrosis Factor-Alpha Inhibits the Replication of Patient-Derived Archetype BK Polyomavirus While Activating Rearranged StrainsLise Lauterbach-Rivière, Lucia Thuringer, Pascal Feld, et al.
World Journal of Urology|June 21, 2020
Robotic-assisted kidney transplantation in obese recipients compared to non-obese recipients: the European experienceThomas Prudhomme, Jean Baptiste Beauval, Marine Lesourd, et al.
Pageof 5